Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03470753 · ClinicalTrials.gov registry record · NA

Impact of Home Exercise Delivery on Compliance & Outcomes for Musculoskeletal Pain

A NA study, sponsored by Dan Rhon.

Completed
Registry status
NA
Development phase
116
Enrollment target

NCT03470753: Completed NA study, sponsored by Dan Rhon.

NCT03470753 is a NA study that has completed, run by Dan Rhon. The registered enrollment target is 116 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03470753, a NA study, has completed, sponsored by Dan Rhon.

COMPLETED
Registry status
NA
Development phase
116 participants
Enrollment target

Study Summary

Patients seeking care for chronic low back or knee pain will be recruited for enrollment, and randomized within two phases (retention and compliance). Patients will consent to a 2-step study design, with independent randomization for each. The initial step will assess retention based on 4 different exercise prescription strategies. This will be assessed short-term, and then the 2nd step will consist of a second independent randomization to receive different reminder strategies to determine their influence on exercise compliance at home.

Primary Outcome

A locally developed tool designed to meet the needs of assessing both exercise retention and compliance. It will capture the subject's ability to recall the name of an exercise, the prescribed sets and repetitions, and the ability to perform an exercise using a 4-point ordinal scale

Interventions

  • OTHER Number of Exercises
  • OTHER Type of Instruction
  • OTHER Delivery Type
  • OTHER Mobile Reminder

Trial Details

FieldValue
Enrollment Target 116 participants
Start Date 2018-01-12
Est. Completion 2019-11-30
Phase NA
Dan Rhon

2 total trials

What the finished NCT03470753 record still lists

NCT03470753 is an interventional study that assigns participants to a tested intervention. The registered 116 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).

The record links to 0 conditions, and to 4 interventions - of which Number of Exercises is the first listed.

NCT03470753 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03470753 about?

NCT03470753 is a clinical study titled "Impact of Home Exercise Delivery on Compliance & Outcomes for Musculoskeletal Pain". Patients seeking care for chronic low back or knee pain will be recruited for enrollment, and randomized within two phases (retention and compliance). Patients will consent to a 2-step study design, with independent randomization for each. The initial step will assess retention based on 4 different ...

What is the current status of trial NCT03470753?

This trial is currently completed. It is a NA study. The enrollment target is 116 participants. The study started on 2018-01-12. Estimated completion is 2019-11-30.

What interventions are being tested in trial NCT03470753?

The interventions under investigation include: Number of Exercises (OTHER), Type of Instruction (OTHER), Delivery Type (OTHER), Mobile Reminder (OTHER).

Who is sponsoring clinical trial NCT03470753?

This trial is sponsored by Dan Rhon, which has 2 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03470753's enrollment target sits among peer trials

116 808th of 2000 higher than 1,191 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03014687 · 116 participants · Phase 4

    Prophylactic Oral Antibiotics on Sinonasal Outcomes Following Endoscopic Transsphenoidal Surgery for Pituitary Lesions

  • NCT03214562 · 116 participants · Phase 1

    Venetoclax With Combination Chemotherapy in Treating Patients With Newly Diagnosed or Relapsed or Refractory Acute Myeloid Leukemia

  • NCT03847467 · 116 participants · Phase 1

    Pilot and Feasibility Study of 2'-FL as a Dietary Supplement in IBD Patients Receiving Stable Maintenance Anti-TNF Therapy

  • NCT04222413 · 116 participants · Phase 1

    Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03470753, the US trial registry maintained by the National Library of Medicine. NCT03470753 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.